8/10/2007

Drugmaker ImClone Systems has appointed former Johnson & Johnson executive John H. Johnson as chief executive, effective Aug. 27. Johnson most recently was group chairman of J&J's worldwide biopharmaceuticals division.

Full Story:
NYTimes.com

Related Summaries